Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

We analyzed the clinical response and the time to relapse after discontinuation of continuous long-term infliximab therapy in patients with ankylosing spondylitis (AS). After 3 years of infliximab therapy, all AS patients (n = 42) discontinued treatment (time point (TP)1) and were visited regularly...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraliakos, Xenofon, Listing, Joachim, Brandt, Jan, Rudwaleit, Martin, Sieper, Joachim, Braun, Juergen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174938/
https://www.ncbi.nlm.nih.gov/pubmed/15899030
http://dx.doi.org/10.1186/ar1693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174938/
https://www.ncbi.nlm.nih.gov/pubmed/15899030
http://dx.doi.org/10.1186/ar1693

Ejemplares similares